Latest Mammary ductal carcinoma Stories

REDWOOD CITY, Calif., May 10, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that, effective May 8, 2013, Palmetto GBA, the designated national contractor for its Oncotype DX® breast cancer test, has expanded its coverage policy for all qualified Medicare patients to include patients with ductal carcinoma in situ (DCIS) following the recent publication of the breast cancer test's DCIS Score in the peer-reviewed, Journal of the National Cancer Institute....

-Determining a breast-cancer patient’s prognosis can be difficult because breast tumors contain many genetic differences and there are many subtypes; -This study combined and analyzed large masses of data from 466 cases of the most common type of breast cancer; -The study identified a small group of molecules that might predict breast-cancer prognosis across many subtypes of the disease and at its early stages; -For the first time a prognostic signature in cancer is composed of both mRNA...

Tomosynthesis (3D mammography) is better able to show infiltrating ductal carcinoma than 2D mammography in women at increased risk of breast cancer, a new study shows. As part of the study, six breast imaging specialists reviewed both 2D and 3D mammography images of 56 cancers diagnosed in patients at intermediate or high risk of breast cancer. "We found that 41% (23/56 cancers) were better seen on tomosynthesis and 4% (2/56) were only seen on tomosynthesis," said Dr. Sarah O'Connell, a...

Patients with early stage breast cancer who were treated with lumpectomy plus radiation may have a better chance of survival compared with those who underwent mastectomy, according to Duke Medicine research. The study, which appears online Jan. 28, 2013, in the journal Cancer, raises new questions as to the comparative effectiveness of breast-conserving therapies such as lumpectomy, where only the tumor and surrounding tissue is surgically removed. “Our findings are observational but...

The combined loss of two tumor suppressor genes, retinoblastoma (RB) and phosphatase and tensin homolog (PTEN) was shown to be strongly associated with progression of DCIS to invasive breast cancer, according to a study published November 28 in the Journal of the National Cancer Institute. Ductal carcinoma in situ (DCIS) is a breast cancer precursor lesion for which there are no established markers defining risk of progression to invasive breast cancer. As a result, the majority of...

SAN FRANCISCO, Sept. 13, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results of a large study that demonstrates the Oncotype DX® Recurrence Score® result to be a robust predictor of distant recurrence, disease-free survival, and overall survival in women with node-positive breast cancer who were treated with anthracycline-containing chemotherapy regimens. Highlighted in the official meeting presscast, these study results will be presented...

Connie K. Ho for redOrbit.com Chemotherapy, radiation therapy and surgery are just a few of the treatments cancer patients undergo. These treatments may be risky, especially for those who are diagnosed with cancer at a young age. A new study led by Dr. Chaya Moskowitz included data that showed women who were treated with radiation to the chest for childhood cancer had a greater chance of developing breast cancer that was similar to women who had BRCA1/2 mutations. The study was revealed...

REDWOOD CITY, Calif., June 1, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of 18 studies being presented at the American Society for Clinical Oncology(®) (ASCO(®)) Annual Meeting taking place June 1-5 in Chicago, Illinois. New data includes validation of the Oncotype DX® colon cancer test in both stage II and stage III disease, the company's first prostate needle biopsy development study, and further evidence of the clinical value of the...

(Ivanhoe Newswire) – A new study shows more than half the women aged 40-49 diagnosed with breast cancer reported no family history. The study, conducted at Elizabeth Wende Breast Care, LLC in Rochester, NY, found that 228 out of 373 cancers (61%) were found in women, aged 40-49 with no family history of breast cancer. Seventeen of the 228 patients did have a prior personal history of breast cancer or abnormal cells at a prior biopsy, and were not included in this analysis. "Out of 211...

Imaging surveillance is an acceptable alternative to surgical excision in patients with benign papilloma, diagnosed at breast core biopsy without cell abnormalities, a new study shows. The study, conducted at the Breast Health Center of California Pacific Medical Center in San Francisco, included 119 papillomas diagnosed at core biopsy without abnormal cells. Imaging follow-up of a minimum of two years without surgical excision was performed on 66 lesions; no cancer was found in this...